{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:57:07Z","timestamp":1787014627612,"version":"build-2736575974"},"reference-count":74,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":3831,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Gastro and Hepatol"],"published-print":{"date-parts":[[1998,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    While European and United States guidelines for the management of\n                    <jats:italic>Helicobacter pylori<\/jats:italic>\n                    infection have been developed, there are no guidelines for the Asian Pacific. International experts and recognised local authorities met in Singapore in 1997 to develop appropriate guidelines, taking into account the high background prevalence of infection, high incidence rates of gastric cancer and resource limitations. Recommendations were made based on randomised controlled trials or where this was not possible, they were based on the current best available evidence or on good clinical practice. A number of acceptable diagnostic tests for infection are available throughout the region. The non\u2010endoscopic methods of choice are the urea breath test or a locally validated antibody test. If endoscopy was to be performed, a biopsy urease test was recommended as the test of first choice, with histology recommended only if this was negative. Post treatment testing was not recommended for all patients; a urea breath test was considered the test of choice if available. All gastric and duodenal ulcer patients who are infected with\n                    <jats:italic>H. pylori<\/jats:italic>\n                    should be treated for\n                    <jats:italic>H. pylori<\/jats:italic>\n                    whether the ulcer is active or in remission. Patients requiring long term non\u2010steroidal anti\u2010inflammatory drug therapy who have a current or recent history of dyspepsia, patients with early gastric cancer or low grade gastric mucosa associated lymphoid tissue lymphoma, and patients with a family history of gastric cancer should be treated. However, it was concluded that there wasn't sufficient evidence that cure of\n                    <jats:italic>H. pylori<\/jats:italic>\n                    infection reduces the risk or prevents the development of gastric adenocarcinoma. Many patients with dyspepsia in the region will request or require early upper endoscopy because of an inherent fear of gastric cancer. However, where endoscopy is not available or is too costly, alternative acceptable approaches were recommended in high risk cancer regions. While evidence is inconclusive to support treatment of\n                    <jats:italic>H. pylori<\/jats:italic>\n                    infection in non\u2010ulcer dyspepsia, it was agreed that treatment be offered to patients with documented infection on a case\u2010by\u2010case basis. Treatment regimens need to attain an eradication rate of 90% or greater by per protocol analysis and 80% or greater by intention\u2010to\u2010treat analysis. A number of 7\u2010day regimens were recommended based on available evidence. These regimens were considered likely to maximize the chances of successful eradication with one course of treatment, thereby reducing the risk of acquired antibiotic resistance and leading to long term cost savings.\n                  <\/jats:p>","DOI":"10.1111\/j.1440-1746.1998.tb00537.x","type":"journal-article","created":{"date-parts":[[2008,3,10]],"date-time":"2008-03-10T20:56:46Z","timestamp":1205182606000},"page":"1-12","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":324,"title":["Report of the 1997 Asia Pacific Consensus Conference on the management of\n                    <i>Helicobacter pylori<\/i>\n                    infection"],"prefix":"10.1111","volume":"13","author":[{"given":"SK","family":"LAM","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NJ","family":"TALLEY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"issue":"2","key":"e_1_2_1_2_2","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1378\/chest.95.2_Supplement.2S","article-title":"Rules of evidence and clinical recommendations on the use of anti\u2010thrombotic agents","volume":"95","author":"Sackett DL","year":"1989","journal-title":"Chest"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1994.tb01249.x"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/166.1.149"},{"key":"e_1_2_1_5_2","first-page":"254","article-title":"Seroepidemiologic study of Helicobacter pylori infection in children in Tapei city","volume":"36","author":"Tsai CJ","year":"1995","journal-title":"Acta Paediatrica Sinica"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01297451"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91111-8"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199612000-00004"},{"key":"e_1_2_1_9_2","first-page":"1780","article-title":"Natural acquisition and spontaneous elimination of Helicobacter pylori infection: Clinical implications","volume":"92","author":"Xia H H\u2010X","year":"1997","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.40.4.454"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/168.3.763"},{"key":"e_1_2_1_12_2","first-page":"1138","article-title":"Do commercial serological kits for Helicobacter pylori infection differ in accuracy?: a meta\u2010analysis","volume":"91","author":"Loy CT","year":"1996","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_2_1_13_2","first-page":"85","article-title":"Long\u2010term follow\u2010up of Helicobacter pylori serology after successful eradication","volume":"91","author":"Cutler AF","year":"1996","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90278-3"},{"key":"e_1_2_1_15_2","first-page":"233","article-title":"Microdose 14C\u2010urea breath test offers diagnosis of Helicobacter pylori in 10 minutes","volume":"91","author":"Peura DA","year":"1996","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1992.tb00963.x"},{"key":"e_1_2_1_17_2","first-page":"915","article-title":"The European 13C\u2010urea breath test for the detection of Helicobacter pylori","volume":"3","author":"Logan RPH","year":"1991","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"e_1_2_1_18_2","first-page":"89","article-title":"Prolonged effect of omeprazole on the 14C\u2010urea breath test","volume":"91","author":"Chey WD","year":"1996","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_2_1_19_2","first-page":"720","article-title":"Proton pump inhibitor and the urease breath test: how long is long enough","volume":"92","author":"Chey WD","year":"1997","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_2_1_20_2","first-page":"721","article-title":"Proton pump inhibitor and the urease breath test: 4 weeks after therapy is best","volume":"92","author":"Graham DY","year":"1997","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.41.1.43"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(96)70002-0"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02091534"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.31.8.850"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199610000-00001"},{"key":"e_1_2_1_26_2","first-page":"463","article-title":"Prospective comparison of H&E, Giemsa, and Genta stains for the diagnosis of Helicobacter pylori Gastrointest","volume":"45","author":"Laine L","year":"1997","journal-title":"Endosc."},{"key":"e_1_2_1_27_2","first-page":"224","article-title":"13C\u2010urea breath test to confirm eradication of Helicobacter pylori","volume":"90","author":"Slomianski A","year":"1995","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1997.tb00491.x"},{"key":"e_1_2_1_29_2","first-page":"A19","article-title":"Which combination therapy can eradicate > 90%Helicobacter pylori infection? A meta\u2010analysis of amoxicillin, metronidazole, tetracycline and clarithromycin containing regimes","volume":"112","author":"Huang JQ","year":"1997","journal-title":"Gastroenterology"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(96)80228-2"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1996.40182000.x"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529609094747"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.1996.tb00003.x"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.1996.tb00027.x"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.116287000.x"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.5.8.959"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.41.1.8"},{"key":"e_1_2_1_38_2","unstructured":"HowdenCW.For which conditions are there evidence\u2010based justification for the treatment ofH pyloriinfectionGastroenterology1997; (in press)."},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03520010077036"},{"key":"e_1_2_1_40_2","first-page":"1398","article-title":"Non\u2010steroidal anti\u2010inflammatory drug associated gastric ulcers do not require Helicobacter pylori for their development","volume":"87","author":"Laine L","year":"1992","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_2_1_41_2","first-page":"1259","article-title":"Long\u2010term non\u2010steroidal anti\u2010inflammatory drug use and gastroduodenal injury: The role of Helicobacter pylori","volume":"102","author":"Loeb DS","year":"1992","journal-title":"Gastroenterology"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.33.12.1608"},{"key":"e_1_2_1_43_2","first-page":"203","article-title":"Helicobacter pylori infection and development of gastric or duodenal ulcer in arthritic patients receiving chronic NSAID therapy. The Misoprostol study group","volume":"89","author":"Kim JG","year":"1994","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.34.12.1677"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.34.9.1162"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.3109\/03009749609082667"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.39.1.22"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)04523-6"},{"key":"e_1_2_1_49_2","first-page":"A144","article-title":"Omeprazole versus misoprostol: different effectiveness in healing gastric and duodenal ulcers versus erosions in NSAID users: The Omnium study","volume":"112","author":"Hawkey CJ","year":"1997","journal-title":"Gastroenterology"},{"key":"e_1_2_1_50_2","first-page":"A338","article-title":"Omeprazole versus ranitidine for healing of NSAID\u2010associated ulcers and erosions in relation to H pylori status: The Astronaut Study","volume":"112","author":"Yeomans ND","year":"1997","journal-title":"Gastroenterology"},{"key":"e_1_2_1_51_2","first-page":"639","article-title":"Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer","volume":"6","author":"Uemura N","year":"1997","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91409-F"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-122-10-199505150-00006"},{"key":"e_1_2_1_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)90113-2"},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199604183341603"},{"key":"e_1_2_1_56_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v112.pm9041231"},{"key":"e_1_2_1_57_2","first-page":"145","article-title":"Functional dyspepsia: a classification with guidelines for diagnosis and management","volume":"4","author":"Talley NJ","year":"1991","journal-title":"Gastroenterol. Int."},{"key":"e_1_2_1_58_2","unstructured":"TalleyNJ BoyceP JonesM.Dyspepsia and health care seeking in a community: How important are psychological factorsDig. Dis. Sci.(in press)."},{"key":"e_1_2_1_59_2","first-page":"A153","article-title":"Anxiety and depression are co\u2010factors determining health care utilization in patients with dyspepsia: A Hong Kong population based study","volume":"112","author":"Hu WHC","year":"1997","journal-title":"Gastroenterology"},{"key":"e_1_2_1_60_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529609094532"},{"key":"e_1_2_1_61_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529609094745"},{"key":"e_1_2_1_62_2","doi-asserted-by":"crossref","unstructured":"TalleyNJ HuntRH.What role doesHelicobacter pyloriplay in non\u2010ulcer dyspepsia? Arguments for and againstH pyloribeing associated with dyspeptic symptoms.Gastroenterology1997; (in press).","DOI":"10.1016\/S0016-5085(97)80016-9"},{"key":"e_1_2_1_63_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529709025095"},{"key":"e_1_2_1_64_2","unstructured":"Veldhuyzen vanZantenS TalleyNJ.Should treatment ofHelicobacterpositive patients with non\u2010ulcer dyspepsia now be recommendedEur. J. Gastroenterol. Hepatol.(in press)."},{"key":"e_1_2_1_65_2","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/0016-5085(94)90007-8","article-title":"A critique of therapeutic trails in H pylori positive functional dyspepsia","volume":"196","author":"Talley NJ","year":"1994","journal-title":"Gastroenterology"},{"key":"e_1_2_1_66_2","first-page":"S7","article-title":"Relationship between Helicobacter pylori infection, atrophic gastritis and gastric carcinoma in a Japanese population","volume":"7","author":"Asaka M","year":"1995","journal-title":"Eur. J. Gastroenterol Hepatol."},{"key":"e_1_2_1_67_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199405053301803"},{"key":"e_1_2_1_68_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199110173251603"},{"key":"e_1_2_1_69_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199110173251604"},{"key":"e_1_2_1_70_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/83.23.1734"},{"key":"e_1_2_1_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)90938-D"},{"key":"e_1_2_1_72_2","first-page":"2111","article-title":"Infection with Helicobacter pylori stains possessing CagA is associated with an increased risk of developing adenocarcinoma of the stomach","volume":"55","author":"Blaser MJ","year":"1995","journal-title":"Cancer Res."},{"key":"e_1_2_1_73_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.40.3.297"},{"key":"e_1_2_1_74_2","first-page":"1785","article-title":"Serological response to specific Helicobacter pylori antigens: antibody against CagA antigens is not predictive of gastric cancer in a developing country","volume":"91","author":"Mitchell HM","year":"1996","journal-title":"Am. J. Gastroemerol."},{"key":"e_1_2_1_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)12249-2"}],"container-title":["Journal of Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1746.1998.tb00537.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1746.1998.tb00537.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T20:38:52Z","timestamp":1698439132000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1746.1998.tb00537.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,1]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,1]]}},"alternative-id":["10.1111\/j.1440-1746.1998.tb00537.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1746.1998.tb00537.x","archive":["Portico"],"relation":{},"ISSN":["0815-9319","1440-1746"],"issn-type":[{"value":"0815-9319","type":"print"},{"value":"1440-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,1]]},"assertion":[{"value":"2008-06-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}